Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KCNRG - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LHFPL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
FKRP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RASAL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAST4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VSTM2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SCARNA13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TBC1D10A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PWRN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
L3MBTL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HS1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LTB4R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IDUA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOLR3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on